Effect of Kshara avalehya in Mutrashmari (Renal calculus)

STUDY TO EVALUATE THE EFFECT OF KSHARA AVALEHYA IN THE MANAGEMENT OF MUTRASHMARI

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/027703

Enrollment

Registered

2020-09-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N20- Calculus of kidney and ureter

Interventions

Intervention1: Kshara Avalehya: Oral administration of Kshara Avalehya in the form of vati in the dosage of 250mg two tablets twice daily after food with 50 ml of milk as adjuvant for 1 days Control

Eligibility

Inclusion criteria

Inclusion criteria: 1.Size of Ashmari less than 10mm irrespective of site, number and type of stone 2.Age group between 16-60 yrs irrespective of gender, occupation, race and socio economic status. Those who are ready to follow the instruction and sign the consent form.

Exclusion criteria

Exclusion criteria: 1.Patients who are suffering with severe systemic disorders like renal failure, Tuberculosis, Poly cystic kidney, hepatic dysfunction and Neoplasms. 2.Known case of uncontrolled hypertension and diabetes mellitus. 3.Patient with acute urinary obstructive symptomatology. Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
1.Mahati Vedana (Severe pain) 2.Mutra Daha (Burning micturition) 3.Sarudira Mutrata (Haematuria) Frequency of micturitionTimepoint: 6 weeks	—

Secondary

Measure	Time frame
Reduction in size of the calculusTimepoint: 6 weeks	—

Countries

India

Contacts

Public ContactDr Mahesh Kumar E S

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital

drmaheshkumar@sdmcahhassan.org91-9844395432

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026